NCT00894231View on ClinicalTrials.gov

Levocetirizine Effect on Nasal Nitric Oxide and Nasal Eosinophils in Subjects With Perennial Allergic Rhinitis

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Perennial Allergic Rhinitis
Interventions
DRUG

levocetirizine (Xyzal)

5mg po QD

DRUG

placebo

sugar tablet

Trial Locations (1)

33134

AAADRS, Coral Gables

Sponsors

Collaborators (1)

UCB Pharma
All Listed Sponsors
lead

AAADRS Clinical Research Center

OTHER

collaborator

UCB Pharma

INDUSTRY